Overview
Status
Active
Registry date
2023-02-15
Share capital
5,000.00 PLN
Registered address
ul. Konduktorska 33, 40-155 Katowice, Poland
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 2 of 2 financial statements were filed late (the longest delay 322 days for 2024).
- 2025not filed
- 202402/06/2026
- 202330/09/2024
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Revenue
This companyUSD 56.35kMedianUSD 165.97kAverageUSD 2.30m
Net profit
This companyUSD 2.57kMedianUSD 1.32kAverageUSD 109.80k
Operating costs
This companyUSD 48.61kMedianUSD 201.81kAverageUSD 2.10m
Assets
This companyUSD 25.93kMedianUSD 118.27kAverageUSD 1.54m
Industry
Authorized Representatives
Przemysław Piotr Szczępowicz – Management Board Member
Robert Roman Romanow – Management Board Member
Manner of representation
Each member of the management board independently is authorized to represent the company and to perform legal acts on its behalf.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Robert Roman Romanówage 55 | 49 | $661.80 | 49% |
Przemysław Piotr Szczępowiczage 48 | 49 | $661.80 | 49% |
Others | 2 | $27.01 | 2% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2016-06-27.
37 1090 2590 0000 0001 3288 3414
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Aug 7, 2020 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $2,578$2,578 | Prezes Banku Gospodarstwa Krajowego | |
| Nov 20, 2019 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $656$656 | Prezes Banku Gospodarstwa Krajowego |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Natur DayS.A. | $680,635.59 | naturday.pl | ||
| Biotriosp. z o.o. | $453,662.22 | biotrio.pl | ||
| Nature's Voicesp. z o.o. | $181,977.76 | naturesvoice.eu | ||
| Pexon Polandsp. z o.o. | $122,615.96 | pexon.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| BIO Animalisp. z o.o. | $49,176.96 | proanimali.com | ||
| Ampliconsp. z o.o. | $48,330.99 | amplicon.pl | ||
| Xenira Pharmaceuticalssp. z o.o. | $26,670.82 | xenirapharma.com | ||
| Bioresearch PharmaS.A. | $21,432.15 | bioresearchpharma.com | ||
| Grupa FinepharmS.A. | – | finepharm.pl |
FAQ
The main business activity of Laventi Group focuses on manufacture of basic pharmaceutical products.
The company was registered in the Polish National Court Register (KRS) on February 15, 2023.
The headquarters is located at: ul. Konduktorska 33, 40-155 Katowice.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
In 2024, the company generated total revenue of $56,349, representing a decrease of 34.6% compared to 2023.
Yes, the company recorded a net profit of $2,568 in 2024, meaning the company decreased its profit by 50.9%.
The largest operating cost category falls under other operating costs. This category amounted to $48,381 in 2024, representing 100% of all operating expenses.
Last updated: 2026-06-03